Myristylation of the Large Surface Protein Is Required for Hepatitis B Virusin VitroInfectivity  by BRUSS, VOLKER et al.
VIROLOGY 218, 396–399 (1996)
ARTICLE NO. 0209
SHORT COMMUNICATION
Myristylation of the Large Surface Protein Is Required for Hepatitis B Virus in Vitro Infectivity
VOLKER BRUSS,*,1 JENS HAGELSTEIN,† ELLEN GERHARDT,* and PETER R. GALLE†
*Department of Medical Microbiology, University of Go¨ttingen, D-37075 Go¨ttingen, Germany; and †Gastroenterology Unit,
Department of Internal Medicine IV, University of Heidelberg, Heidelberg, Germany
Received October 10, 1995; accepted February 2, 1996
The large surface protein (L) of the enveloped hepatitis B virus (HBV) is myristylated at glycine 2. To investigate whether
this fatty acid moiety is required for HBV infectivity we made use of a point mutant in which the myristyl acceptor was
mutated to a nonfunctional alanine. The mutant virus and a wild-type control were expressed in a human hepatoma cell
line by transfection of genomic DNA constructs. Comparable amounts of virions were secreted by both strains as measured
by the endogenous polymerase activity of immunoprecipitated virions. The presentation of an N-terminal epitope of L on
the virion surface was not influenced by the mutation. To test the infectivity of this mutant virus primary human hepatocytes
were incubated with the media of transfected cells. The covalently circular closed HBV DNA molecules generated after
infection were discriminated from the open circular DNA genomes of inoculated virions by a sensitive PCR-based technique.
The experiments demonstrated that the wild type was infectious but not the myristate negative mutant. This reflects the
phenotype of an homologous duck hepatitis B virus mutant although the N-terminal L protein domains of this virus and of
HBV show no primary sequence homology. q 1996 Academic Press, Inc.
One of the major unsolved questions in hepatitis B surface proteins which contain no capsid structure and
virology is how the virus targets and enters its host cell. are therefore not infectious. The exterior of the virion
Our ignorance in this field is in part the consequence of which determines targeting of the host cell and early
the narrow host range and pronounced organ tropism of entry steps is formed by three related surface proteins
the hepatitis B virus (HBV): it infects only humans or (6) which are probably embedded into lipid. The large
higher primates so that no suitable animal system is at surface protein L is 400 amino acid residues long (virus
hand and it replicates only in hepatocytes (for a review subtype ad) and encoded by the env gene of the virus.
see (1)). Permanent cell lines derived from human hepa- The middle sized surface protein M corresponds to the
tocytes, like HepG2 and HuH7, have lost susceptibility C-terminal 281 amino acid residues of L and is expressed
to viral infection although they produce infectious virus from an internal start codon in the env frame. Finally, the
after transfection of genomic DNA constructs (2). Only small surface protein S corresponds to the C-terminal
primary human hepatocytes which are of limited avail- 226 amino acid residues of M and L because the S
ability and difficult to culture are infectable, however, just protein is expressed from yet another distal start codon
for a few hours after explantation and seeding and they of the env frame. The start sites for M and S protein
produce only low amounts of progeny virus (3–5). There- divide the sequence of L into the N-terminal preS1 and
fore, most work on the infection process was performed the central preS2 domains which are followed by the S
in a related system using the duck hepatitis B virus region.
(DHBV) which belongs to the same family (hepadnaviri- Domains of the surface proteins which are external
dae). Although primary duck hepatocytes are readily in virions and subviral particles and therefore potential
available and susceptible to viral infection, the mecha- ligands for a putative virus receptor have been defined
nism of DHBV uptake has not yet been clarified. by several approaches, e.g., by epitope mapping with
The infectious unit of HBV is an enveloped virion of monoclonal antibodies (7) and characterization of prote-
42 nm diameter which contains an icosahedral nucleo- ase-sensitive sites (8) and by analyzing the transmem-
capsid. Subviral particles of spherical or filamentous brane topology of the surface proteins in the endoplas-
shape and 22 nm diameter are also secreted from in- mic reticulum (ER) membrane shortly after biosynthesis
fected cells and represent complexes of lipid and HBV (8–12). These studies revealed that a central region in
the S domain which forms the major antigenic determi-
nants of subviral particles as well as the preS2 domain1 To whom correspondence and reprint requests should be ad-
dressed. Fax: 1551 395860. E-mail: vbruss@gwdg.de. of M and the preS1 and preS2 domains of L are external,
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whereas N-terminal and C-terminal parts of S are hidden.
One exceptional result was obtained from these investi-
gations: the L protein is anchored in the ER membrane
by a type II signal within its S region and exposes its
preS domain at the cytosolic side of the ER, which corre-
sponds topologically to the interior side of the virion en-
velope (8, 11, 12). Only posttranslationally, the preS do-
mains of approximately half of the L chains (8) are trans-
located by an unknown mechanism across the lipid
barrier to become exposed on the outside.
The HBV L protein, like the L protein of DHBV (13) is
cotranslationally modified by covalent attachment of a
myristic acid residue to glycine 2 (14). A point mutation
which blocked linkage of the fatty acid had no influence
on virion morphogenesis, neither for HBV (15) nor for
FIG. 1. Detection of hepatitis B virions in the media of HepG2 cellsDHBV (13). However, this mutation blocked in vivo infec-
transfected with wild-type and myristate-negative mutant HBV DNA.
tivity of DHBV (13). We made use of the in vitro infection HepG2 cells were transiently transfected in 10-cm tissue dishes with
system with primary human hepatocytes to assess the a cloned one and one-half mer HBV genome as described (15). A wild-
type (WT) construct and a point mutant (myr0) were used in which therequirement of the myristyl moiety for the infectivity of
myristyl acceptor glycine 2 and a second potential acceptor glycine 13HBV. For this purpose we transiently expressed an over-
(for details see text) of L were mutated to alanine (15). Five days afterlength head-to-tail one and one-half mer construct of the
transfection virion were immunoprecipitated from 0.8-ml aliquots of the
wild-type HBV genome, subtype adw2 (pHBV1.5) (15), cleared medium with goat anti-HBs (s) or an anti-preS1 antibody (S1),
and a derivative (pRV1.5myr0) (15) into which two point and naked as well as total nucleocapsids were immunoprecipitated
with rabbit anti-HBc in the absence (c0) or presence (c/) of mildmutations had been introduced by site-directed in vitro
detergent, respectively, as described (15). The viral DNA genome ofmutagenesis in HepG2 cells. The first mutation changed
the precipitated particles was labeled after addition of radioactive de-the second codon of the preS1 frame (GGA) to the ala-
soxynucleotide triphosphates by the endogenous polymerase of the
nine codon GCA which is not a functional myristyl ac- virus which elongates the incomplete plus strand. The viral DNA was
ceptor. The second mutation changed the 13th codon of isolated, separated on an agarose gel, and used for autoradiography
as described (15). (A) The signal from wild-type (lanes 3 to 5) andpreS1 (GGG for glycine) to GCG (alanine). This triplet is
mutant virus (lanes 6 to 8) was similar, indicating that comparabledirectly preceded by a protein translation start codon.
amounts of virions were produced. Only very low amounts of nakedUsage of this site in the wild-type context by scanning
nucleocapsids were released (lanes 3 and 6). In lanes 1 and 2, 2.5 1
ribosomes which ignored the first initiation site would 105 and 0.5 1 105 virions, respectively, from a human serum were
possibly produce an N-terminally truncated myristylated directly employed in the endogenous polymerase reaction. (B) Wild-
type (lanes 1 and 2) and mutant (lanes 3 and 4) virions were immunopre-L protein and low amounts of this side product could
cipitated with anti-HBs (lanes 1 and 3) and the monoclonal anti-preS1suppress a mutant phenotype. The two mutations do not
antibody MA18/7 (lanes 2 and 4) prior to the endogenous polymeraselower the expression or stability of the L protein but abol-
reaction demonstrating that the block of L myristylation did not prevent
ish myristylation completely (16). the appearance of the preS1 domain on the virion surface. The low
Five days after transfection the media were harvested recovery with the monoclonal antibody was probably due to weaker
binding to the protein A used for immobilization of the antibody.and the presence of virions was demonstrated (Fig. 1A)
by the following technique (15). Virions (lanes 5 and 8)
and naked nucleocapsids (lanes 3 and 6) were immuno-
transfected cells contained similar amounts of virionsprecipitated with antibodies (anti-HBs) against the sur-
(compare lane 5 with lane 8) and only low amounts offace antigen (HBsAg) and antibodies (anti-HBc) against
naked nucleocapsids (lanes 3 and 6). Quantification bythe capsid antigen (HBcAg), respectively. In addition, en-
comparing the signal generated from 0.8 ml medium perveloped and naked nucleocapsids were simultaneously
lane with 2.5 1 105 (lane 1) and 0.5 1 105 (lane 2) virionsimmunoprecipitated by anti-HBc in the presence of mild
from a serum of a highly viremic virus carrier, respec-detergent which opens the virion envelope (lanes 4 and
tively, revealed that both media contained approximately7). Virions and nucleocapsids contain an open circular
1 to 1.5 1 105 virions per milliliter.partially double-stranded 3.2-kb DNA genome and a DNA
It was possible that the block of L myristylation inhib-polymerase which is able to elongate the incomplete
ited the posttranslational translocation of preS1 domainDNA strand (17). We labeled the genome with the help
to the virion surface. To test this we verified the presenceof this reaction by adding radioactive desoxynucleotide
of preS1 domains at the exterior of the virions by immuno-triphosphates. The reaction products were isolated, sep-
precipitation with the monoclonal antibody MA18/7arated on an agarose gel, and visualized by autoradio-
which binds to an N-terminal epitope in preS1 (18) priorgraphy. The analysis showed that the media of wild-type
(Fig. 1A, lanes 3 to 5) and mutant (Fig. 1A, lanes 6 to 8) to detection of the virus genome by the endogenous
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polymerase reaction (Fig. 1B). Both, wild-type (lane 2)
and mutant (lane 4) virions were bound by the preS1
antibody with the same efficiency. The virion recovery
was lower than with anti-HBs (compare lane 1 and 3)
probably because the monoclonal antibody bound less
well to the protein A used for immobilization. We con-
clude from this that the block of L myristylation did not
prevent translocation of preS1 domains to the virion sur-
face.
To test the infectivity of the mutant HBV we inoculated
primary human hepatocytes with 0.5 ml of the media
containing approximately 0.6 1 105 wild-type and myris-
tate-negative mutant viruses, respectively. After exten-
FIG. 2. Detection of total (A) and infecting ccc (B) HBV DNA in primary
sive washing batches of cells were lysed at Days 1 and human hepatocytes. For infection primary human hepatocytes were
4 postinfection and viral DNA was prepared. The pres- prepared and cultured as described (4). Cells in 12-well dishes were
incubated over night for infection with 0.5 ml of medium from wild-typeence of HBV DNA could be demonstrated by PCR (Fig.
and mutant-transfected cells containing approximately 0.61 105 virions2A) at both time points and for both wild-type (lanes 1
and extensively washed. Cells were lysed 1 and 4 days postinfectionand 2) and mutant (in duplicate, lanes 3 to 6) viruses.
(d.p.i.) by incubation with 0.1 ml 50 mM KCl, 10 mM Tris–Cl, pH 8.3,
The amount of virus at Day 1 was similar in the case of 0.45% (v/v) Tween 20, 0.45% (v/v) Nonidet P-40, 50 mg proteinase K for
the wild type (lane 1) and one of the experiments with 2 hr at 567. The protease was inactivated by incubation at 957 for 10
min. Ten ml of the treated lysate were used for PCR with a primer pairthe mutant (lane 5), whereas the other assay with the
detecting total HBV DNA (plus primer nt 682–709: 5*TGC CAT TTGmutant (lane 3) showed a higher amount. This variability
TTC AGT GGT TCG TAG GGC; minus primer nt 1571–1548: 5*CCGwas probably due to variations in the adherence of virus
GCA GAT GAG AAG GCA CAG ACG) (A) or a primer pair embracing
particles to the cell culture. The wild type signal in- the 5* ends of the viral minus and plus strands as they appear in virion
creased from Day 1 (lane 1) to Day 4 (lane 2), probably DNA but not in the infecting viral episomal DNA in the cell nucleus
(plus primer nt 1253–1276: 5*CCT CTG CCG ATC CAT ACT GCG GAA;due to virus replication, whereas the signals from the
minus primer nt 2398–2375: 5*CTG CGA GGC GAG GGA GTT CTTmutant virus remained constant (compare lane 3 with
CTT) (B). With the second primer pair the ccc form of the viral DNA islane 4 and line 5 with lane 6).
detected 103 times more sensitive than the virion DNA (19). For PCR
This approach, however, cannot differentiate between 2 ng of each primer, 20 nmol of each dNTP, buffer supplied by Stra-
passively adhering virions and virions which had actively tagene, and 2.5 U Taq polymerase (Stratagene) were used in 0.1 ml
vol. The mixture was incubated for 3 min at 947 and then for 30 cyclesentered the host cell. Therefore, we used a PCR-based
with 1 min at 947, 1 min at 587, and 2 min at 727. Ten ml of the reactiontechnique which has a high specificity for the first viral
products were separated on a 1% agarose gel, transferred onto a nylonDNA intermediate appearing after infection (19): In the
membrane, and detected by a DIG-labeled probe prepared by random
virus particle the DNA molecule is open circular. One primed DNA synthesis using cloned total HBV DNA as the template,
strand (the minus strand) has full-length and a nick at alkaline phosphatase conjugated anti-DIG-antibodies (Boehringer), and
CSPD substrate (Tropix). The films were exposed for 30 min. (A) Totalposition 1825 (numbering starts with the deoxycytidine
viral DNA was detectable in cultures incubated with wild-type (WT,of the unique EcoRI site). The other incomplete (plus)
lanes 1 and 2) and mutant (myr0, in duplicate, lanes 3 to 6) virus 1 andstrand starts at nucleotide 1598 and overlaps this nick
4 d.p.i. (B) The ccc form of the viral DNA which is synthesized after
(for a review see (20)). After infection the viral genome infection in the host cell could be detected only in case of the WT (lane
is transported into the cell nucleus and repaired to yield 1) but not in case of the mutant (in duplicate, lanes 2 and 3) 4 d.p.i.
We conclude that mutant virions which lack the myristyl moiety at thea covalently closed circular (ccc) DNA molecule. A PCR
L protein were not infectious in vitro.reaction using primers which embrace the nick on the
minus strand and the 5* end of the plus strand can distin-
guish between the two forms of the viral genome. Detec- myristylation of the L protein is also dispensable for virion
tion of the open circular form was at least 103 times less formation but required for in vivo infectivity (13). This is,
sensitive than detection of the ccc form (19). With this however, not a trivial finding because the preS se-
technique the ccc form of the viral genome could be quences of both virus have no primary sequence homol-
found 4 days postinfection only in the case of the wild ogy. Furthermore, the functional difference of both pro-
type (Fig. 2B, lane 1) but not in case of the mutant (in teins was illustrated by the inability of the DHBV L protein
duplicate, lanes 2 and 3). The experiment was performed to substitute HBV L in the envelope of a phenotypically
three times with identical outcome. We conclude from mixed human virus or to coassemble with HBV S protein
this that the infection with the myristate-negative HBV into mixed subviral particles (21). On the other hand,
mutant was blocked or was below the limit of detection, mutational analysis revealed that the C-terminal part of
whereas infection with the wild-type virus could clearly the preS domains of both proteins was required for virion
be demonstrated in our system. formation but not the N-terminal part (22, 23). Mutations
in this region affected infectivity of DHBV (22). Our experi-This result is consistent with the DHBV model where
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